Your browser doesn't support javascript.
loading
Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score.
Kim, Nicole J; Vutien, Philip; Berry, Kristin; Ioannou, George N.
Afiliação
  • Kim NJ; Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington.
  • Vutien P; Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington.
  • Berry K; Research and Development, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington.
  • Ioannou GN; Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington; Division of Gastroenterology, Department of Medicine, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington. Electronic address: georgei@medicine.washington.edu.
Gastroenterology ; 163(4): 1104-1106.e3, 2022 10.
Article em En | MEDLINE | ID: mdl-35777481
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Hepatite C Crônica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Hepatite C Crônica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2022 Tipo de documento: Article